PDF herunterladen
Planta Med 2016; 82(11/12): 952-960
DOI: 10.1055/s-0042-107254
Reviews
Georg Thieme Verlag KG Stuttgart · New York

Immunmodulatory and Antiproliferative Properties of Rhodiola Species[*]

Mari-Carmen Recio
Department of Pharmacology, Faculty of Pharmacy, University of Valencia, Valencia, Spain
,
Rosa-María Giner
Department of Pharmacology, Faculty of Pharmacy, University of Valencia, Valencia, Spain
,
Salvador Máñez
Department of Pharmacology, Faculty of Pharmacy, University of Valencia, Valencia, Spain
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 12. März 2016
revised 11. April 2016

accepted 12. April 2016

Publikationsdatum:
25. Mai 2016 (online)

   Lizenzen und Reprints

Abstract

The traditional medicines of Asia and Europe have long used various Rhodiola species, which are endemic to the subarctic areas of the northern hemisphere, as tonic, adaptogen, antidepressant, and anti-inflammatory drugs. In order to establish the therapeutic uses of these plants in modern medicine, the pharmacological effects of Rhodiola sp. have been widely studied. Indeed, the most amply researched species, Rhodiola rosea, has been shown to possess antioxidant, adaptogenic, antistress, antimicrobial, immunomodulatory, angiomodulatory, and antitumoral effects. Salidroside (p-hydroxyphenethyl-β-D-glucoside), a major compound in Rhodiola, seems to be responsible for many of the effects observed with Rhodiola extracts.

The aim of this paper is to review the pharmacological effects not only of various Rhodiola species, mainly R. rosea along with Rhodiola imbricata, Rhodiola algida, and Rhodiola crenulata, but also of salidroside, focusing especially on its antioxidant, immunomodulatory, antitumoral, and antiproliferative activities, as well as to describe their therapeutic significance in disease management. Although previous pharmacological studies have established a scientific basis for possible therapeutic uses of Rhodiola extracts and salidroside, high-quality, randomized, controlled clinical trials are still needed.

Key words

Rhodiola - salidroside - adaptatogen - antitumor - immunostimulant - antioxidant

* Dedicated to Professor Dr. Dr. h. c. mult. Kurt Hostettmann in recognition of his outstanding contribution to natural product research.


 

  • References

  • 1 Grech-Baran M, Sykłowska-Baranek K, Pietrosiuk A. Biotechnological approaches to enhance salidroside, rosin and its derivatives production in selected Rhodiola spp. in vitro cultures. Phytochem Rev 2015; 14: 657-674
    CrossrefPubMedGoogle Scholar
  • 2 GBIF 2010. Biodiversity occurrence data provided by Global Biodiversity Information Facility. Available at. http://data.gbif.org Accessed March 04, 2016
    PubMedGoogle Scholar
  • 3 European Medicines Agency, Committee on Herbal Medicinal Products. Assessment report on Rhodiola rosea L., rhizoma et radix. EMA/HMPC/232100/2011; 27 March 2012.
    PubMedGoogle Scholar
  • 4 Sarwar GR, Qaiser M. Distribution pattern, ecology and endemism of family Crassulaceae in Pakistan and Kashmir. Pak J Bot 2012; 44: 2055-2061
    PubMedGoogle Scholar
  • 5 Zhengyi W, Raven PH. Flora of China, Vol. 8. Beijing: Science Press; and St. Louis: Missouri Botanical Garden Press; 2001: 251-268
    Google Scholar
  • 6 Radomska-Lesniewska D, Skopinski P, Balan BJ, Bialoszewska A, Józwiak J, Rokicki D, Skopinska-Rózewska E, Borecka A, Hevelke A. Angiomodulatory properties of Rhodiola spp. and other natural antioxidants. Centr Eur J Immunol 2015; 40: 249-262
    PubMedGoogle Scholar
  • 7 Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 2010; 17: 481-493
    CrossrefPubMedGoogle Scholar
  • 8 Cuerrier A, Ampong-Nyarko K. Rhodiola rosea . Boca Raton: CRC Press; 2015
    Google Scholar
  • 9 Panossian A, Hamm R, Kadioglu O, Wilkman G, Efferth T. Synergy antagonism of active constituents of ADAPT-232 on transcriptional level of metabolic regulation of isolated neuroglial cells. Front Neurosci 2013; 7: 1-14
    PubMedGoogle Scholar
  • 10 Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 2015; 74: 5-17
    CrossrefPubMedGoogle Scholar
  • 11 Zdanowski R, Lewicki S, Skopińska-Różewska E, Buchwald W, Mrozikiewicz M, Stankiewicz W. Alcohol- and water-based extracts obtained from Rhodiola rosea affect differently the number and metabolic activity of circulating granulocytes in Balb/c mice. Ann Agric Environ Med 2014; 21: 120-123
    PubMedGoogle Scholar
  • 12 Lin SC, Chin LW, Chao PC, Lai YY, Lin LY, Chou MY, Chou MC, Wei JC, Yang CC. In vivo Th1 and Th2 cytokine modulation effects of Rhodiola rosea standardised solution and its major constituent, salidroside. Phytother Res 2011; 25: 1604-1611
    CrossrefPubMedGoogle Scholar
  • 13 Hotchkiss RS, Tinsley KW, Karl IE. Role of apoptotic cell death in sepsis. Scand J Infect Dis 2003; 35: 585-592
    CrossrefPubMedGoogle Scholar
  • 14 Liu MW, Su MX, Zhang W, Zhang LM, Wang YH, Qian CY. Rhodiola rosea suppresses thymus T-lymphocyte apoptosis by downregulating tumor necrosis factor-α-induced protein 8-like-2 in septic rats. Int J Mol Med 2015; 36: 386-398
    PubMedGoogle Scholar
  • 15 Xu X, Tan C, Li P, Zhang S, Pang X, Liu H, Li L, Sun X, Zhang Y, Wu H, Chen X, Ge Q. Changes of cytokines during a spaceflight analog – a 45-day head-down bed rest. PLoS One 2013; 8: e77401
    CrossrefPubMedGoogle Scholar
  • 16 Skopińska-Rózewska E, Sokolnicka I, Siwicki AK, Stankiewicz W, Dabrowski MP, Buchwald W, Krajewska-Patan A, Mielcarek S, Mścisz A, Furmanowa M. Dose-dependent in vivo effect of Rhodiola and Echinacea on the mitogen-induced lymphocyte proliferation in mice. Pol J Vet Sci 2011; 14: 265-272
    PubMedGoogle Scholar
  • 17 Chiang HM, Chien YC, Wu CH, Kuo YH, Wu WC, Pan YY, Su YH, Wen KC. Hydroalcoholic extract of Rhodiola rosea L. (Crassulaceae) and its hydrolysate inhibit melanogenesis in B16F0 cells regulating the CREB/MITF/tyrosynase pathway. Food Chem Toxicol 2014; 65: 129-139
    CrossrefPubMedGoogle Scholar
  • 18 Palumbo DR, Occhiuto F, Spadaro F, Circosta C. Rhodiola rosea extract protects human cortical neurons against glutamate and hydrogen peroxide-induced cell death through reduction in the accumulation of intracellular calcium. Phytother Res 2012; 26: 878-883
    CrossrefPubMedGoogle Scholar
  • 19 Liu Z, Li X, Simoneau AR, Jafari M, Zi X. Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy. Mol Carcinog 2012; 51: 257-267
    CrossrefPubMedGoogle Scholar
  • 20 Cai Z, Li W, Wang H, Yan W, Zhou Y, Wang G, Cui J, Wang F. Antitumor effects of a purified polysaccharide from Rhodiola rosea and its action mechanism. Carbohydr Polym 2012; 90: 296-300
    CrossrefPubMedGoogle Scholar
  • 21 Mishra KP, Ganju L, Chanda S, Karan D, Sawhney RC. Aqueous extract of Rhodiola imbricata rhizome stimulates Toll-like receptor 4, granzyme-B and Th1 cytokines in vitro . Immunobiology 2009; 214: 27-31
    CrossrefPubMedGoogle Scholar
  • 22 Mishra KP, Ganju L, Singh SB. Anti-cellular and immunomodulatory potential of aqueous extract of Rhodiola imbricata rhizome. Immunopharmacol Immunotoxicol 2012; 34: 513-518
    CrossrefPubMedGoogle Scholar
  • 23 Diwaker D, Mishra KP, Ganju L, Singh SB. Rhodiola inhibits dengue virus multiplication by inducing innate immune response genes RIG-I, MDA5 and ISG in human monocytes. Arch Virol 2014; 159: 1975-1986
    CrossrefPubMedGoogle Scholar
  • 24 Senthilkumar R, Parimelazhagan T, Chaurasia OP, Srivastava RB. Free radical scavenging property and antiproliferative activity of Rhodiola imbricata Edgew extracts in HT-29 human colon cancer cells. Asian Pac J Trop Med 2013; 6: 11-19
    CrossrefPubMedGoogle Scholar
  • 25 Chawla R, Jaiswal S, Kumar R, Arora R, Sharma RK. Himalayan bioresource Rhodiola imbricata as a promising radioprotector for nuclear and radiological emergencies. J Pharm Bioallied Sci 2010; 2: 213-219
    CrossrefPubMedGoogle Scholar
  • 26 Zhou JT, Li CY, Wang CH, Wang YF, Wang XD, Wang HT, Zhu Y, Jiang MM, Gao XM. Phenolic compounds from the roots of Rhodiola crenulata and their antioxidant and inducing IFN-γ production activities. Molecules 2015; 20: 13725-13739
    CrossrefPubMedGoogle Scholar
  • 27 Zhu C, Guan F, Wang C, Jin LH. The protective effects of Rhodiola crenulata extracts on Drosophila melanogaster gut immunity induced by bacteria and SDS toxicity. Phytother Res 2014; 28: 1861-1866
    CrossrefPubMedGoogle Scholar
  • 28 Bassa LM, Jacobs C, Gregory K, Henchey E, Ser-Dolansky J, Schneider SS. Rhodiola crenulata induces an early estrogenic response and reduced proliferation and tumorsphere formation over time in MCF7 breast cancer cells. Phytomedicine 2016; 23: 87-94
    CrossrefPubMedGoogle Scholar
  • 29 Mora MC, Bassa LM, Wong KE, Tirabasi MV, Arenas RB, Schneider SS. Rhodiola crenulata inhibits Wnt/β-catenin signaling in glioblastoma. J Surg Res 2015; 197: 247-255
    CrossrefPubMedGoogle Scholar
  • 30 Dudek MC, Wong KE, Bassa LM, Mora MC, Ser-Dolansky J, Henneberry JM, Crisi GM, Arenas RB, Schneider SS. Antineoplastic effects of Rhodiola crenulata treatment on B16-F10 melanoma. Tumour Biol 2015; 36: 9795-9805
    CrossrefPubMedGoogle Scholar
  • 31 Li HX, Sze SC, Tong Y, Ng TB. Production of Th1- and Th2-dependent cytokines induced by the Chinese medicine herb, Rhodiola algida, on human peripheral blood monocytes. J Ethnopharmacol 2009; 123: 257-266
    CrossrefPubMedGoogle Scholar
  • 32 Loo WTY, Jin LJ, Chow LWC, Cheung MNB, Wang M. Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients. Expert Opin Investig Drugs 2010; 19: S91-S100
    CrossrefPubMedGoogle Scholar
  • 33 Qi YJ, Cui S, Lu DX, Yang YZ, Luo Y, Ma L, Ma Y, Wuren T, Chang R, Qi L, Ben BJ, Han J, Ge RL. Effects of the aqueous extract of a Tibetan herb, Rhodiola algida var. tangutica on proliferation and HIF-1α, HIF-2α expression in MCF-7 cells under hypoxic condition in vitro . Cancer Cell Int 2015; 15: 81
    CrossrefPubMedGoogle Scholar
  • 34 Zhang H, Shen WS, Gao CH, Deng LC, Shen D. Protective effects of salidroside on epirubicin-induced early left ventricular regional systolic dysfunction in patients with breast cancer. Drugs R D 2012; 12: 101-106
    CrossrefPubMedGoogle Scholar
  • 35 Shi TY, Feng SF, Xing JH, Wu YM, Li XQ, Zhang N, Tian Z, Liu SB, Zhao MG. Neuroprotective effects of Salidroside and its analogue tyrosol galactoside against focal cerebral ischemia in vivo and H2O2-induced neurotoxicity in vitro . Neurotox Res 2012; 21: 358-367
    CrossrefPubMedGoogle Scholar
  • 36 Zhang JK, Yang L, Meng GL, Yuan Z, Fan J, Li D, Chen JZ, Shi TY, Hu HM, Wei BY, Luo ZJ, Liu J. Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators. PLoS One 2013; 8: e57251
    CrossrefPubMedGoogle Scholar
  • 37 Li D, Fu Y, Zhang W, Su G, Liu B, Guo M, Li F, Liang D, Liu Z, Zhang X, Cao Y, Zhang N, Yang Z. Salidroside attenuates inflammatory responses by suppressing nuclear factor-κB and mitogen activated protein kinases activation in lipopolysaccharide-induced mastitis in mice. Inflamm Res 2013; 62: 9-15
    CrossrefPubMedGoogle Scholar
  • 38 Guan S, He J, Guo W, Wei J, Lu J, Deng X. Adjuvant effects of salidroside from Rhodiola rosea L. on the immune responses to ovalbumin in mice. Immunopharmacol Immunotoxicol 2011; 33: 738-743
    CrossrefPubMedGoogle Scholar
  • 39 Hu X, Lin S, Yu D, Qiu S, Zhang X, Mei R. A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines. Cell Biol Toxicol 2010; 26: 499-507
    CrossrefPubMedGoogle Scholar
  • 40 Liu X, Peng X, Hu Z, Zhao Q, He J, Li J, Zhong X. Effects of over-expression of ANXA10 gene on proliferation and apoptosis of hepatocellular carcinoma cell line HepG2. J Huazhong Univ Sci Technolog Med Sci 2012; 32: 669-674
    CrossrefPubMedGoogle Scholar
  • 41 Skopińska-Rózewska E, Malinowski M, Wasiutyński A, Sommer E, Furmanowa M, Mazurkiewicz M, Siwicki AK. The influence of Rhodiola quadrifida 50 % hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice. Pol J Vet Sci 2008; 11: 97-104
    PubMedGoogle Scholar
  • 42 Sun C, Wang Z, Zheng Q, Zhang H. Salidroside inhibits migration and invasion of human fibrosarcoma HT1080 cells. Phytomedicine 2012; 19: 355-363
    CrossrefPubMedGoogle Scholar
  • 43 Lu L, Yuan J, Zhang S. Rejuvenating activity of salidroside (SDS): dietary intake of SDS enhances the immune response of aged rats. Age (Dordr) 2013; 35: 637-646
    CrossrefPubMedGoogle Scholar
  • 44 Zhao X, Lu Y, Tao Y, Huang Y, Wang D, Hu Y, Liu J, Wu Y, Yu Y, Liu C. Salidroside liposome formulation enhances the activity of dendritic cells and immune responses. Int Immunopharmacol 2013; 17: 1134-1140
    CrossrefPubMedGoogle Scholar
  • 45 Hu B, Zou Y, Liu S, Wang J, Zhu J, Li J, Bo L, Deng X. Salidroside attenuates concanavalin A-induced hepatitis via modulating cytokines secretion and lymphocyte migration in mice. Mediators Inflamm 2014; 2014: 314081
    PubMedGoogle Scholar
  • 46 Chen JJ, Zhang NF, Mao GX, He XB, Zhan YC, Deng HB, Song DQ, Li DD, Li ZR, Si SY, Qiu Q, Wang Z. Salidroside stimulates osteoblast differentiation through BMP signaling pathway. Food Chem Toxicol 2013; 62: 499-505
    CrossrefPubMedGoogle Scholar
  • 47 Chen X, Zhang Q, Cheng Q, Ding F. Protective effect of salidroside against H2O2-induced cell apoptosis in primary culture of rat hippocampal neurons. Mol Cell Biochem 2009; 332: 85-93
    CrossrefPubMedGoogle Scholar
  • 48 Yu S, Shen Y, Liu J, Ding F. Involvement of ERK1/2 pathway in neuroprotection by salidroside against hydrogen peroxide-induced apoptotic cell death. J Mol Neurosci 2010; 40: 321-331
    CrossrefPubMedGoogle Scholar
  • 49 Li X, Ye X, Li X, Sun X, Liang Q, Tao L, Kang X, Chen J. Salidroside protects against MPP+-induced apoptosis in PC12 cells by inhibiting the NO pathway. Brain Res 2011; 1382: 9-18
    CrossrefPubMedGoogle Scholar
  • 50 Zhang L, Ding W, Sun H, Zhou Q, Huang J, Li X, Xie Y, Chen J. Salidroside protects PC12 cells from MPP+-induced apoptosis via activation of the PI3K/Akt pathway. Food Chem Toxicol 2012; 50: 2591-2597
    CrossrefPubMedGoogle Scholar
  • 51 Xu MC, Gao XF, Ruan C, Ge ZR, Lu JD, Zhang JJ, Zhang Y, Wang L, Shi HM. miR-103 Regulates oxidative stress by targeting the Bcl2/adenovirus E1B 19kDa interacting protein 3 in HUVECs. Oxid Med Cell Longev 2015; 2015: 489647
    PubMedGoogle Scholar
  • 52 Tan CB, Gao M, Xu WR, Yang XY, Zhu XM, Du GH. Protective effects of salidroside on endothelial cell apoptosis induced by cobalt chloride. Biol Pharm Bull 2009; 32: 1359-1363
    CrossrefPubMedGoogle Scholar
  • 53 Hu X, Lin S, Yu D, Qiu S, Zhang X, Mei R. A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines. Cell Biol Toxicol 2010; 26: 499-507
    CrossrefPubMedGoogle Scholar
  • 54 Zhao G, Shi A, Fan Z, Du Y. Salidroside inhibits the growth of human breast cancer in vitro and in vivo . Oncol Rep 2015; 33: 2553-2560
    PubMedGoogle Scholar
  • 55 Sun C, Wang Z, Zheng Q, Zhang H. Salidroside inhibits migration and invasion of human fibrosarcoma HT1080 cells. Phytomedicine 2012; 19: 355-363
    CrossrefPubMedGoogle Scholar
  • 56 Wang J, Li JZ, Lu AX, Zhang KF, Li BJ. Anticancer effect of salidroside on A459 lung cancer cells through inhibition of oxidative stress and phosphor-p38 expression. Oncol Lett 2014; 7: 1159-1164
    PubMedGoogle Scholar
  • 57 Zhang Y, Yao Y, Wang H, Guo Y, Zhang H, Chen L. Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment. Chin J Cancer Res 2013; 25: 520-526
    PubMedGoogle Scholar
  • 58 Sun KX, Xia HW, Xia RL. Anticancer effect of salidroside on colon cancer through inhibiting JAK2/STAT3 signaling pathway. Int J Clin Exp Pathol 2015; 8: 615-621
    PubMedGoogle Scholar
  • 59 Li YR, Cao W, Guo J, Miao S, Ding GR, Li KC, Wang J, Guo GZ. Comparative investigations on the protective effects of rhodioside, ciwujianoside-B and astragaloside IV on radiation injuries of the hematopoietic system in mice. Phytother Res 2011; 25: 644-653
    CrossrefPubMedGoogle Scholar
  • 60 Li X, Sipple J, Pang Q, Du W. Salidroside stimulates DNA repair enzyme Parp-1 activity in mouse HSC maintenance. Blood 2012; 119: 4162-4173
    CrossrefPubMedGoogle Scholar
  • 61 Li Q, Zhou XD, Kolosov VP, Perelman JM. Salidroside reduces cold-induced mucin production by inhibiting TRPM8 activation. Int J Mol Med 2013; 32: 637-646
    PubMedGoogle Scholar
  • 62 Yin D, Yao W, Chen S, Hu R, Gao X. Salidroside, the main active compound of Rhodiola plants, inhibits high glucose-induced mesangial cell proliferation. Planta Med 2009; 75: 1191-1195
    Artikel in Thieme ConnectPubMedGoogle Scholar